Erratum to "AWAJI criteria are not always superior to the previous criteria: A meta-analysis" by Jae-Sik Jang and Jong Seok Bae, published in the June 2015 issue of Muscle & Nerve [Muscle Nerve, 51, 6, (2015), 822-829] DOI:10.1002/mus.24575;Awaji criteria are not always superior to the previous criteria: A meta-analysis

Muscle and Nerve

Volumn 51, Issue 6, 2015, Pages 822-829

  Jang, Jae Sik ^a,b   Bae, Jong Seok ^c  

^a Inje University College of Medicine   (South Korea)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c Hallym University College of Medicine   (South Korea)

Author keywords

ALS; Amyotrophic lateral sclerosis; Awaji criteria; Diagnostic criteria; Revised El Esocorial criteria; Sensitivity

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; LABORATORY TEST; META ANALYSIS; MOTONEURON; PRIORITY JOURNAL; BIBLIOGRAPHIC DATABASE; DEMOGRAPHY; ELECTROMYOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; STATISTICS AND NUMERICAL DATA;

AMYOTROPHIC LATERAL SCLEROSIS; DATABASES, BIBLIOGRAPHIC; DEMOGRAPHY; EARLY DIAGNOSIS; ELECTROMYOGRAPHY; HUMANS; ROC CURVE;

EID: 84929517631     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24730     Document Type: Erratum

References (30)

1. Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009;8:94-109.
2. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-1431.
3. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1227-1233.
4. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258-1261.
5. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008;119:497-503.
6. de Carvalho MD, Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 2009;10:53-57.
7. Okita T, Nodera H, Shibuta Y, Nodera A, Asanuma K, Shimatani Y, et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria? J Neurol Sci 2011;302:29-32.
8. Schrooten M, Smetcoren C, Robberecht W, Van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 2011;70:79-83.
9. Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler 2010;11:497-501.
10. Chen A, Weimer L, Brannagan T III, Colin M, Andrews J, Mitsumoto H, et al. Experience with the Awaji Island modifications to the ALS diagnostic criteria. Muscle Nerve 2010;42:831-832.
11. Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 2010;81:646-649.
12. Noto Y, Misawa S, Kanai K, Shibuya K, Isose S, Nasu S, et al. Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset. Clin Neurophysiol 2012;123:382-385.
13. Krarup C. Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis. Clin Neurophysiol 2011;122:414-422.
14. Higashihara M, Sonoo M, Imafuku I, Fukutake T, Kamakura K, Inoue K, et al. Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm. Muscle Nerve 2012;45:175-182.
15. Gawel M, Kuzma-Kozakiewicz M, Szmidt-Salkowska E, Kaminska A. Are we really closer to improving the diagnostic sensitivity in ALS patients with Awaji criteria? Amyotroph Lateral Scler Frontotemporal Degener 2014;15:257-261.
16. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
17. Benatar M, Tandan R. The Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: have we put the cart before the horse? Muscle Nerve 2011;43:461-463.
18. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
19. Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012;69:1410-1417.
20. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
21. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6:31.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
23. Deeks JJ, Altman DG, J . BM. Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In: Egger M, Davey, Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context, 2nd ed. London: BMJ Publication Group; 2001. p 313-335.
24. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56:1129-1135.
25. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002;21:1237-1256.
26. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-1316.
27. de Carvalho M, Bentes C, Evangelista T, Luis ML. Fibrillation and sharp-waves: do we need them to diagnose ALS? Amyotroph Lateral Scler Other Motor Neuron Disord 1999;1:29-32.
28. Cappellari A, Brioschi A, Barbieri S, Braga M, Scarlato G, Silani V. A tentative interpretation of electromyographic regional differences in bulbar- and limb-onset ALS. Neurology 1999;52:644-646.
29. Wilbourn AJ. Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: the Lambert and the El Escorial criteria. J Neurol Sci 1998;160(Suppl 1):S25-S29.
30. Mills KR. Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome. Brain 2010;133:3458-3469.